2001
Akpek G, Lenz G, Lee SM, Sanchorawala V, Wright DG, Colarusso T, Waraska K, Lerner A, Vosburgh E, Skinner M, Comenzo RL
Immunologic recovery after autologous blood stem cell transpantation in patients with AL-amyloidosis. Bone Marrow Transplantation, 28: 1105-1109, 2001.
Choufani EB, Sanchorawala V, Skinner M, Wright DG, Seldin DC
Acquired factor X deficiency in patients with AL amyloidosis: incidence, bleeding manifestations, and response to high dose chemotherapy. Blood, 97: 1885-1887, 2001.
Chung CM, Connors LH, Benson MB and Walsh MT
Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis. Amyloid: Journal of Protein Folding Disorders, 8: 75-83, 2001.
Connors LH, Lim A, Prokaeva T, Metayer M, Costello CE, Skinner M
Familial transthyretin amyloidosis: recent Boston experience. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp 506-508, 2001.
Costello CE , Lim A, O’Connor PB, Prokaeva T, Connors LH, Skinner M
Identification of novel transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp.331-333, 2001.
Dember LM, Sanchorawala V, Comenzo RL, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M
Effect of intravenous melphalan and autologous blood stem cell transplant on AL amyloidosis-associated renal disease. Annals of Int Med, 134: 746-753, 2001.
Ellis JM, Prokaeva T, Mulligan N, O’Hara CJ, Connors LH, Skinner M, Seldin DC
VL gene usage in primary amyloidosis. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp. 180-182, 2001.
Gorson KC, Hedley-White ET, Skinner M
A 64-year old woman with peripheral neuropathy, paraproteinemia, and lymphadenopathy. New Eng J Med, 344: 917-923, 2001.
Liao R, Teller P, Jain M, Connors LH, Skinner M, Falk, RH, Apstein CS
Acute infusion of Bence Jones protein from patients with amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation, 104: 1594-1597, 2001.
Libbey CA, Connors LH, Swan N, Skinner M
Abdominal fat tissue aspirate for diagnosis of amyloidosis- 10 year experience. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp 497-499, 2001.
Lim A, Wally J, Walsh MT, Skinner M, Costello CE
Detection and characterization of post-translational modifications in amyloidogenic kappa 1 light chain proteins by mass spectrometric peptide mapping. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp 199-201, 2001.
Lim A, Wally J, Walsh MT, Skinner M, Costello (PDF)
Identification and localization of a cysteinyl post-translational modification in an amyloidogenic kappa 1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem., 295: 45-56, 2001.
Ng B, Davidoff R, Skinner M, and Falk RH
Paradoxical Clinical and Echocardiographic Findings in Senile versus AL Amyloidosis. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp 392-394, 2001.
Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M
Status report: high-dose chemotherapy with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplantation, 28: 637-642, 2001.
Sanchorawala V, Wright DG, Seldin DC, Muir L, Falk RH, Finn K, Skinner M
Low Dose Continuous Oral Melphalan for the Treatment of AL Amyloidosis. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp 190-192, 2001.
Shaz BH, Lewis WD, Skinner M, Khettry U
Livers from patients with apolipoprotein A1 amyloidosis are not suitable as “domino” donors. Mod Pathol, 14: 577-580, 2001.
Skinner M, Sanchorawala V, Falk RF, Dember LM, Seldin DC, Berk J, Finn K, Libbey CA, Quillen K, LaValley M, and Wright DG
AL Amyloidosis: Severity of Illness, Treatment Decisions and Outcome in 554 Patients. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp 221-223, 2001.
Swan N, Mulcahy E, Magnani BJ, Skinner M, and O’Hara CJ
Bone Marrow Biopsy Findings in AL Amyloidosis Following Treatment With High-Dose Melphalan and Autologous Stem Cell Support; Correlation with Immunofixation Electrophoresis. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp 253-255, 2001.
Wright DG, Sanchorawala V, Taper J, Seldin DC, Falk RH, Dember LM, Berk J, Finn K, Quillen K, and Skinner M
High Dose Intravenous Melphalan and Autologous Stem Cell Transplantation for the Treatment of AL Amyloidosis: Morbidity and Mortality. In: Amyloid and Amyloidosis, Ed by M Bely and A Apathy. Budapest, pp 193-195, 2001.
Yazaki M, Liepnieks J, Yamashita T, Guenther B, Skinner M, Benson MD
Renal amyloidosis caused by a novel stop-codon mutation in the apolipoprotein A2 gene. Kidney International, 60: 1658-1665, 2001.
|
|
